ID: ALA3797935

Max Phase: Preclinical

Molecular Formula: C10H8N2O3

Molecular Weight: 204.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N#Cc1ccc(C/C(=N/O)C(=O)O)cc1

Standard InChI:  InChI=1S/C10H8N2O3/c11-6-8-3-1-7(2-4-8)5-9(12-15)10(13)14/h1-4,15H,5H2,(H,13,14)/b12-9-

Standard InChI Key:  KFLUGOTXZLOJRY-XFXZXTDPSA-N

Associated Targets(Human)

C-terminal-binding protein 2 36 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 204.19Molecular Weight (Monoisotopic): 204.0535AlogP: 1.02#Rotatable Bonds: 3
Polar Surface Area: 93.68Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.66CX Basic pKa: CX LogP: 1.77CX LogD: -1.74
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.44Np Likeness Score: -0.30

References

1. Korwar S, Morris BL, Parikh HI, Coover RA, Doughty TW, Love IM, Hilbert BJ, Royer WE, Kellogg GE, Grossman SR, Ellis KC..  (2016)  Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).,  24  (12): [PMID:27156192] [10.1016/j.bmc.2016.04.037]

Source